http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34747967

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Research Support, N.I.H., Extramural
issn 2041-1723
issueIdentifier 1
pageRange 4760-
publicationName Nature Communications
startingPage 4760
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_336ae0a312865ff4263b48641de3fde5
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0df6de4240820d7702b8fd7241d20763
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a4a4d52950e33267ecdc80a8f3c095ea
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c05a7a00e25730436ac96451a7bf9313
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59
bibliographicCitation Al-Nakouzi N, Wang CK, Oo HZ, Nelepcu I, Lallous N, Spliid CB, Khazamipour N, Lo J, Truong S, Collins C, Hui D, Esfandnia S, Adomat H, Clausen TM, Gustavsson T, Choudhary S, Dagil R, Corey E, Wang Y, Chauchereau A, Fazli L, Esko JD, Salanti A, Nelson PS, Gleave ME, Daugaard M. Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer. Nature Communications. 2022 Aug 13;13(1):4760. doi: 10.1038/s41467-022-32530-7.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9d063e83febc51cef0920efe5c32b0c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ca26a6a3433b4c20743f9fbea916c98
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8383-055X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_420a9ac87111bdaaa3a02c160fe174b2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d574d90144c46ce1fa451d07e595b0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8647d099253df6c4d3fde38bb7a0140c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c975ab0a21cfed5834a69003683e0c7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_083ae6f6a0d4b7a74f2527baf48aaae1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_807b8179aef6caeb8b9dccaac3a83f87
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9208-6934
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dae84ea2cb35648421272b7963e720e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62bf5da76050aee810f81217fea49eff
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5594-0716
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffd697bc8c6dea689d88329af64b2200
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60970449f1c62beea7b56f7f42339831
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4653-2884
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d626d14b04439179f6bdd0cc69289e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1393427bd6bd7181c1e525f2f8471a4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac3da38ca1dd98849e200c0ec4c91059
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df4a19367662a5398d7fb7335a27ad1c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98a5ec7835e7f11ad48651841ac62be3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a17b891e5757340ee44c01b107bab0bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74f610488b982098bc1c028bab0afcc4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9244-3807
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d43c24ea5a09a10dbe38b4f1a06e929
date 2022-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC9376089
https://doi.org/10.1038/s41467-022-32530-7
https://pubmed.ncbi.nlm.nih.gov/35963852
isPartOf https://portal.issn.org/resource/ISSN/2041-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37539
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer
discusses http://id.nlm.nih.gov/mesh/M0001106
http://id.nlm.nih.gov/mesh/M0004318
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beee0846290a2e523c00aec9ef5735a3
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21873177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477707

Total number of triples: 62.